Description: Iris Medicine is an early-stage life sciences company pioneering the future of RNA therapies. The Iris approach is allele-selective and broadly applicable across diverse patient populations.
Iris small binding RNAs (sbRNAs) mimic natural RNAs and modulate gene expression through tightly regulated, highly selective binding events.
The sbRNA platform unlocks multiple therapeutic approaches: from allele-selective inhibition to gene activation to splicing modulation.
Our mission is to address a range of serious diseases, beginning with devastating repeat expansion disorders. There are over twenty known repeat expansion diseases today, and that list continues to grow.